Bottom line
RYHCX vs HGHAX: the short answer
RYHCX (Health Care Fund) and HGHAX (The Hartford Healthcare Fund) are both mutual funds.
HGHAX is cheaper at 1.33% vs 2.4% — a difference of $107 a year per $10,000 invested.
HGHAX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
RYHCX vs HGHAX side by side
| RYHCX | HGHAX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Guggenheim | Hartford |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 2.4% | 1.33% |
| Annual cost per $10k | $240 | $133 |
| 10-yr cost on $10k (prospectus) | $2,782 | $2,063 |
| Max front load | 0% | 5.5% |
| 12b-1 fee | 1% | 0.25% |
| 1-yr return | +12.3% | — |
| 5-yr return (annualized) | +4.1% | — |
| 10-yr return (annualized) | +6.8% | — |
| Best quarter | +18.4% | +20.9% |
| Worst quarter | −14.6% | −15.7% |
| Net assets (fund) | $19.4M | $772.2M |
| Number of holdings | 135 | 80 |
| Portfolio turnover | 244% | 49% |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | RYHCX | HGHAX | Difference |
|---|---|---|---|
| 2025 | +13.3% | +15.6% | −2.3% |
| 2024 | −0.4% | 0.0% | −0.4% |
| 2023 | +4.8% | +3.8% | +1.0% |
| 2022 | −12.5% | −11.7% | −0.7% |
| 2021 | +18.1% | +10.0% | +8.1% |
| 2020 | +17.7% | +22.6% | −4.8% |
| 2019 | +21.6% | +33.3% | −11.7% |
| 2018 | +0.5% | −3.0% | +3.5% |
| 2017 | +22.3% | +21.6% | +0.7% |
| 2016 | −10.3% | −8.6% | −1.7% |
Source: Fund prospectus bar charts
Holdings overlap
18 of RYHCX's top 25 holdings also appear in HGHAX's top 25.
| Holding | RYHCX | HGHAX |
|---|---|---|
| Eli Lilly & Company | 3.63% | 12.03% |
| Johnson & Johnson | 2.88% | 6.75% |
| Abbvie Inc | 2.52% | 4.21% |
| Unitedhealth Group Inc | 2.22% | 4.74% |
| Merck & Company Inc | 2.04% | 6.00% |
| Thermo Fisher Scientific Inc | 1.61% | 1.58% |
| Amgen Inc | 1.56% | 1.39% |
| Abbott Laboratories | 1.42% | 1.82% |
| Vertex Pharmaceuticals Inc | 1.34% | 2.64% |
| Cvs Health Corp | 1.31% | 2.84% |
| Intuitive Surgical Inc | 1.31% | 2.88% |
| Danaher Corp | 1.30% | 2.57% |
| Stryker Corp | 1.21% | 1.24% |
| Elevance Health Inc | 1.02% | 3.00% |
| Regeneron Pharmaceuticals Inc | 0.90% | 2.02% |
Source: SEC Form N-PORT
RYHCX top 10
- Eli Lilly & Company — 3.63%
- Johnson & Johnson — 2.88%
- Abbvie Inc — 2.52%
- Unitedhealth Group Inc — 2.22%
- Merck & Company Inc — 2.04%
- Thermo Fisher Scientific Inc — 1.61%
- Amgen Inc — 1.56%
- Abbott Laboratories — 1.42%
- Gilead Sciences Inc — 1.39%
- Vertex Pharmaceuticals Inc — 1.34%
HGHAX top 10
- Eli Lilly & Co — 12.03%
- Johnson & Johnson — 6.75%
- Merck & Co Inc — 6.00%
- UnitedHealth Group Inc — 4.74%
- AbbVie Inc — 4.21%
- Elevance Health Inc — 3.00%
- Intuitive Surgical Inc — 2.88%
- CVS Health Corp — 2.84%
- Vertex Pharmaceuticals Inc — 2.64%
- Danaher Corp — 2.57%
FAQ
What is the difference between RYHCX and HGHAX?
Which is cheaper, RYHCX or HGHAX?
Should I own both RYHCX and HGHAX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.